Skip to content

Comparing Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) sacrocolpopexy and conventional laparoscopic sacrocolpopexy: a randomized controlled trial

Comparing Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) sacrocolpopexy and conventional laparoscopic sacrocolpopexy: a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051879
Enrollment
Unknown
Registered
2021-10-09
Start date
2021-04-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic organ prolapse

Interventions

1:Transvaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) sacralcolpopexy
2:conventional laparoscopic sacralcolpopexy

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with grade III or more apical prolapses by POP-Q system and no needs for pregnancy any more.

Exclusion criteria

Exclusion criteria: History of rectal surgery, suspected rectovaginal endometriosis or malignancy, history of pelvic inflammatory disease, active lower genital tract infection, virginity, pregnancy or failure to provide written informed content.

Design outcomes

Primary

MeasureTime frame
The proportion of women successfully treated by the intended approach without conversion to another approach;

Secondary

MeasureTime frame
postoperative pain scores measured using a VAS;the duration of surgery (min);postoperative hospitalization days;POP-Q evaluation before and 6 weeks/ 3 months/ 1 year after the surgery;intraoperative or postoperative( 6 weeks/ 3 months/ 1 year after the surgery) complications;Questionaires before and 6 weeks/ 3 months/ 1 year after the surgery;blood loss during surgery (ml);

Countries

China

Contacts

Public ContactJuan Liu

The Third Affiliated Hospital of Guangzhou Medical University

liujuan90011@163.com+86 18998321609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026